Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Salesforce NASDAQ:CRM Chair and CEO Marc Benioff sold a total of $536,321 worth of shares in the company on October 15, 2025. The sales occurred at prices ranging from $236.6085 to $240.5481. The software giant, currently valued at $234.41 billion, maintains a strong financial health score according to InvestingPro analysis, with a perfect Piotroski Score of 9, indicating excellent operational efficiency.
According to a Form 4 filing with the Securities and Exchange Commission, Benioff sold 629 shares at prices ranging from $236.1600 to $237.1500, 611 shares at prices ranging from $237.1600 to $238.1500, 175 shares at prices ranging from $238.1600 to $238.9555, 403 shares at prices ranging from $239.1671 to $240.1600 and 432 shares at prices ranging from $240.1700 to $240.8900. With the stock trading at a P/E ratio of 35.78, InvestingPro’s Fair Value analysis suggests the stock may be undervalued despite its premium multiple.
On the same day, Benioff also exercised options to acquire 2,250 shares of Salesforce common stock at a price of $161.50, for a total value of $363,375.
These transactions were executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted on January 9, 2025. Following these transactions, Benioff directly owns 11,911,571 shares. He also indirectly owns 10,000,000 shares through the Marc Benioff Fund LLC and 107,000 shares by trust.
In other recent news, Salesforce has been the focus of several analyst reviews following its recent events, including Dreamforce and Investor Day. Goldman Sachs reiterated its Buy rating on Salesforce, setting a price target of $385. The firm noted Salesforce’s long-term guidance, which targets over $60 billion in revenue by fiscal 2030, with an expected compound annual growth rate (CAGR) of approximately 10% and operating margins reaching about 40%. Cantor Fitzgerald maintained its Overweight rating and a $325 price target, emphasizing Salesforce’s strategic positioning in enterprise AI and the launch of Agentforce 360.
Meanwhile, UBS and DA Davidson both maintained their Neutral ratings on Salesforce, with price targets of $260 and $225, respectively. UBS described the Investor Day as a "net positive" for the company, while DA Davidson noted updates on innovation acceleration and new long-term financial targets. Guggenheim also maintained its Neutral rating, expressing skepticism about the ambitious revenue target for fiscal year 2030, which would necessitate a 10%+ organic revenue growth CAGR from FY26 to FY30. These developments provide investors with insights into Salesforce’s strategic direction and financial outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.